Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial

被引：0

作者：

Maria J. G. T. Vehreschild

Petar Atanasov

Kateryna Yurko

Cristian Oancea

Georgi Popov

Valentina Smesnoi

Gheorghe Placinta

Hella Kohlhof

Daniel Vitt

Evelyn Peelen

Jelena Mihajlović

Andreas R. Muehler

机构：

[1] Goethe University Frankfurt,Department of Internal Medicine, Infectious Diseases, Medizinische Klinik II, University Hospital Frankfurt

[2] UMHATEM “N.I.Pirogov” EAD,Clinic of Internal Diseases

[3] Kharkiv National Medical University,Infectious Diseases

[4] University of Medicine and Pharmacy “Victor Babeş” Timişoara,Clinic of Infectious Disease

[5] Military Medical Academy-Sofia,undefined

[6] PMSI Clinical Hospital of Infectious Diseases “Toma Ciorba”,undefined

[7] Section 3,undefined

[8] Bulevardul Ştefan Cel Mare şi Sfânt,undefined

[9] Nr 163,undefined

[10] PMSI Clinical Hospital of Infectious Diseases “Toma Ciorba”,undefined

[11] Section 4,undefined

[12] Bulevardul Ştefan Cel Mare şi Sfânt,undefined

[13] nr 163,undefined

[14] Immunic AG,undefined

来源：

Infectious Diseases and Therapy | 2022年 / 11卷

关键词：

COVID-19; Dihydroorotate dehydrogenase inhibitor; Vidofludimus calcium;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2159 / 2176

页数：17

共 50 条

[41] Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Troseid, Marius
Arribas, Jose R.
Assoumou, Lambert
Holten, Aleksander Rygh
Poissy, Julien
Terzic, Vida
Mazzaferri, Fulvia
Rodriguez-Bano, Jesus
Eustace, Joe
Hites, Maya
Joannidis, Michael
Paiva, Jose-Artur
Reuter, Jean
Puentmann, Isabel
Patrick-Brown, Thale D. J. H.
Westerheim, Elin
Nezvalova-Henriksen, Katerina
Beniguel, Lydie
Dahl, Tuva Borresdatter
Bouscambert, Maude
Halanova, Monika
Peterfi, Zoltan
Tsiodras, Sotirios
Rezek, Michael
Briel, Matthias
Unal, Serhat
Schlegel, Martin
Ader, Florence
Lacombe, Karine
Amdal, Cecilie Delphin
Rodrigues, Serge
Tonby, Kristian
Gaudet, Alexandre
Heggelund, Lars
Mootien, Joy
Johannessen, Asgeir
Moller, Jannicke Horjen
Diaz Pollan, Beatriz
Tveita, Anders Aune
Kildal, Anders Benjamin
Richard, Jean-Christophe
Dalgard, Olav
Simensen, Victoria Charlotte
Balde, Aliou
de Gastines, Lucie
del Alamo, Marta
Aydin, Burc
Lund-Johansen, Fridtjof
Trabaud, Mary-Anne
Diallo, Alpha
CRITICAL CARE, 2023, 27 (01)
[42] Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Marius Trøseid
José R. Arribas
Lambert Assoumou
Aleksander Rygh Holten
Julien Poissy
Vida Terzić
Fulvia Mazzaferri
Jesús Rodríguez Baño
Joe Eustace
Maya Hites
Michael Joannidis
José-Artur Paiva
Jean Reuter
Isabel Püntmann
Thale D. J. H. Patrick-Brown
Elin Westerheim
Katerina Nezvalova-Henriksen
Lydie Beniguel
Tuva Børresdatter Dahl
Maude Bouscambert
Monika Halanova
Zoltán Péterfi
Sotirios Tsiodras
Michael Rezek
Matthias Briel
Serhat Ünal
Martin Schlegel
Florence Ader
Karine Lacombe
Cecilie Delphin Amdal
Serge Rodrigues
Kristian Tonby
Alexandre Gaudet
Lars Heggelund
Joy Mootien
Asgeir Johannessen
Jannicke Horjen Møller
Beatriz Diaz Pollan
Anders Aune Tveita
Anders Benjamin Kildal
Jean-Christophe Richard
Olav Dalgard
Victoria Charlotte Simensen
Aliou Baldé
Lucie de Gastines
Marta del Álamo
Burç Aydin
Fridtjof Lund-Johansen
Mary-Anne Trabaud
Alpha Diallo
Critical Care, 27
[43] Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial
Aryan, Hossein
Farahani, Ramin Hamidi
Chamanara, Mohsen
Elyasi, Sepideh
Jaafari, Mahmoud Reza
Haddad, Mahboubeh
Sani, Ashraf Tavanaee
Ardalan, Mohamed Afshar
Mosaed, Reza
PHYTOTHERAPY RESEARCH, 2022, 36 (10) : 3924 - 3931
[44] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Julio Vallejos
Rodrigo Zoni
María Bangher
Silvina Villamandos
Angelina Bobadilla
Fabian Plano
Claudia Campias
Evangelina Chaparro Campias
Maria Fernanda Medina
Fernando Achinelli
Hector Andres Guglielmone
Jorge Ojeda
Diego Farizano Salazar
Gerardo Andino
Pablo Kawerin
Silvana Dellamea
Antonia Cristina Aquino
Victor Flores
Carolina N. Martemucci
Silvina Maria Martinez
Juan Emanuel Segovia
Paola Itati Reynoso
Noelia Carolina Sosa
Mariana Elizabeth Robledo
Joaquina Maria Guarrochena
Maria Mercedes Vernengo
Natalia Ruiz Diaz
Elba Meza
María Gabriela Aguirre
BMC Infectious Diseases, 21
[45] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Vallejos, Julio
Zoni, Rodrigo
Bangher, Maria
Villamandos, Silvina
Bobadilla, Angelina
Plano, Fabian
Campias, Claudia
Chaparro Campias, Evangelina
Fernanda Medina, Maria
Achinelli, Fernando
Andres Guglielmone, Hector
Ojeda, Jorge
Farizano Salazar, Diego
Andino, Gerardo
Kawerin, Pablo
Dellamea, Silvana
Cristina Aquino, Antonia
Flores, Victor
Martemucci, Carolina N.
Maria Martinez, Silvina
Emanuel Segovia, Juan
Itati Reynoso, Paola
Carolina Sosa, Noelia
Elizabeth Robledo, Mariana
Maria Guarrochena, Joaquina
Mercedes Vernengo, Maria
Ruiz Diaz, Natalia
Meza, Elba
Gabriela Aguirre, Maria
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[46] Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Huang, Daniel Q.
Ajmera, Veeral
Tomaszewski, Christian
LaFree, Andrew
Bettencourt, Ricki
Thompson, Wesley K.
Smith, Davey M.
Malhotra, Atul
Mehta, Ravindra L.
Tolia, Vaishal
Yin, Jeffrey
Insel, Paul A.
Leachman, Stone
Jung, Jinho
Collier, Summer
Richards, Lisa
Woods, Kristin
Amangurbanova, Maral
Bhatt, Archana
Zhang, Xinlian
Penciu, Oana M.
Zarich, Stuart
Retta, Tamrat
Harkins, Michelle S.
Teixeira, J. Pedro
Chinnock, Brian
Utay, Netanya S.
Lake, Jordan E.
Loomba, Rohit
ADVANCES IN THERAPY, 2023, 40 (11) : 4805 - 4816
[47] Mycobacterium vaccae Nebulization in the Treatment of COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
Lin, Yan-rong
Wu, Feng-yao
Xiao, Huan
Huang, Jian-lin
Gong, Bei-bei
Li, You-ling
Lu, Ning
Jiang, Xiao-hong
Sun, Qi-xiang
Zhang, Jian-feng
Hu, Jun-tao
Zhao, Yong-xiang
Li, Chao-qian
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (02) : 108 - 114
[48] Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Daniel Q. Huang
Veeral Ajmera
Christian Tomaszewski
Andrew LaFree
Ricki Bettencourt
Wesley K. Thompson
Davey M. Smith
Atul Malhotra
Ravindra L. Mehta
Vaishal Tolia
Jeffrey Yin
Paul A. Insel
Stone Leachman
Jinho Jung
Summer Collier
Lisa Richards
Kristin Woods
Maral Amangurbanova
Archana Bhatt
Xinlian Zhang
Oana M. Penciu
Stuart Zarich
Tamrat Retta
Michelle S. Harkins
J. Pedro Teixeira
Brian Chinnock
Netanya S. Utay
Jordan E. Lake
Rohit Loomba
Advances in Therapy, 2023, 40 : 4805 - 4816
[49] Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
Jain, Mamta K.
De Lemos, James A.
McGuire, Darren K.
Ayers, Colby.
Eitson, Jennifer L.
Sanchez, Claudia L.
Kamel, Dena
Meisner, Jessica A.
Thomas, Emilia V.
Hegde, Anita A.
Mocherla, Satish
Strebe, Joslyn K.
Li, Xilong
Williams, Noelle S.
Xing, Chao
Ahmed, Mahmoud S.
Wang, Ping
Sadek, Hesham A.
Schoggins, John W.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[50] Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
Yeming Wang
Fei Zhou
Dingyu Zhang
Jianping Zhao
Ronghui Du
Yi Hu
Zhenshun Cheng
Ling Gao
Yang Jin
Guangwei Luo
Shouzhi Fu
Qiaofa Lu
Guanhua Du
Ke Wang
Yang Lu
Guohui Fan
Yi Zhang
Ying Liu
Shunan Ruan
Wen Liu
Thomas Jaki
Frederick G. Hayden
Peter W. Horby
Bin Cao
Chen Wang
Trials, 21

← 1 2 3 4 5 →